Heart Disease Clinical Trials in Cleveland

Showing 361-380 of 448 trials

Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique

NCT01272453

This is a prospective, controlled observational trial of patients undergoing clinically indicated cardiothoracic computed tomography (CT), including pulmonary or aortic angiography and coronary CT angiography (CCTA).

Coronary Artery DiseaseAortic AneurysmPulmonary Embolism

Gilbert L. Raff, MD2,640 participantsStarted Jan 2011

San Diego, California, United States • Boston, Massachusetts, United States • Royal Oak, Michigan, United States +6 more locations

COMPLETEDPhase 4< 1 mile

Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

NCT00153101

The Ongoing Telmisartan Alone and in combination wiht Ramipril Global Endpoint trial (ONTARGET): The primary objectives are to determine if (a) telmisartan 80mg daily and ramipril 10mg daily combination therapy is more effective in reducing the composite endpoint of Cardiovascular Death (CV) death, Myocardial infarction (MI), stroke or hospitalization for Congestive Heart Failure (CHF) compared with ramipril 10mg alone; and (b) telmisartan 80mg daily is at least as effective as (i.e. not less effective than) ramipril 10mg daily, on this endpoint. Telmisartan Randomised Assessment Study in Angiotension converting Enzyme inhibitor intolerant subjects with Cardiovascular Disease. (TRANSCEND): The primary objective of the study is to determine if treatment with telmisartan 80mg daily is superior to placebo reducing the composite endpoint of Cardiovascular Death (CV), Myocardial Infarction ( MI)I, stroke or hospitalization for Congestive Heart Failure (CHF) in patients who are intolerant to Angiotension Converting Enzyme inhibitors.

Cardiovascular Diseases

Boehringer Ingelheim31,546 participantsStarted Nov 2001

Athens, Alabama, United States • Birmingham, Alabama, United States • Phoenix, Arizona, United States +729 more locations

Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique

Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

Heart Disease Trials in Other Cities

Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart Failure

Gas Exchange for Predicting Hospital Heart Failure Readmissions

A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA)

Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)

OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.

Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.

Drug Eluting Stent Registry of Thrombosis

TAXUS PERSEUS Workhorse

OVATIO CRT and SITUS OTW LV Lead Post Approval Study

A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People

Genetic Risk Assessment of Defibrillator Events

Radial Artery Versus Saphenous Vein Grafts in Coronary Artery Bypass Surgery

Reducing Risk Factors in Peripheral Arterial Disease

Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers

Clinical Evaluation of the CADenceTM System in Detection of Coronary Artery Diseases

Evaluating the Effectiveness of Sildenafil at Improving Health Outcomes and Exercise Ability in People With Diastolic Heart Failure (The RELAX Study)

Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT Device

Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge

Other Conditions in Cleveland